Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douwe Postmus

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 20, 2015
Applying Multiple Criteria Decision Analysis to Comparative Benefit-Risk Assessment: Choosing among Statins in Primary PreventionTommi Tervonen, Huseyin Naci, Gert van Valkenhoef, et al.
The American Journal of Cardiology|April 21, 2012
Long-term compliance with nonpharmacologic treatment of patients with heart failureMaurice M W Nieuwenhuis, Tiny Jaarsma, Dirk J van Veldhuisen, et al.
Kidney International|July 5, 2024
Clinical trial designs to assess treatment effects on glomerular filtration rate declineHiddo J L Heerspink, Dustin J Little, Lars Frison, et al.
The Lancet. Oncology|April 17, 2025
Use of patient-reported outcomes to inform symptom and functional outcomes in cancer drug regulatory decisions: challenges and future directionsFrancesco Pignatti, Peter Mol, Chantal Quinten, et al.
Translational Lung Cancer Research|March 11, 2026
Association of CT-assessed sarcopenia and the development of immune-related adverse events and overall survival: a multistate survival analysisErick Suazo-Zepeda, Marjolein A Heuvelmans, Douwe Postmus, et al.
Drug Safety|February 15, 2023
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey StudySonia Roldan Munoz, Douwe Postmus, Sieta T de Vries, et al.
Frontiers in Pharmacology|March 15, 2021
Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference StudySonia Roldan Munoz, Douwe Postmus, Sieta T de Vries, et al.
American Heart Journal|December 6, 2011
A trial-based economic evaluation of 2 nurse-led disease management programs in heart failureDouwe Postmus, Anees A Abdul Pari, Tiny Jaarsma, et al.
Dento Maxillo Facial Radiology|May 11, 2018
Diagnostic reliability of low dose multidetector CT and cone beam CT in maxillofacial trauma-an experimental blinded and randomized studyRomke Rozema, Michiel Hj Doff, Peter Ma van Ooijen, et al.
Biometrical Journal. Biometrische Zeitschrift|July 22, 2014
Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectivesEwout W Steyerberg, Moniek M Vedder, Maarten J G Leening, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 20, 2015
Applying Multiple Criteria Decision Analysis to Comparative Benefit-Risk Assessment: Choosing among Statins in Primary PreventionTommi Tervonen, Huseyin Naci, Gert van Valkenhoef, et al.
The American Journal of Cardiology|April 21, 2012
Long-term compliance with nonpharmacologic treatment of patients with heart failureMaurice M W Nieuwenhuis, Tiny Jaarsma, Dirk J van Veldhuisen, et al.
Kidney International|July 5, 2024
Clinical trial designs to assess treatment effects on glomerular filtration rate declineHiddo J L Heerspink, Dustin J Little, Lars Frison, et al.
The Lancet. Oncology|April 17, 2025
Use of patient-reported outcomes to inform symptom and functional outcomes in cancer drug regulatory decisions: challenges and future directionsFrancesco Pignatti, Peter Mol, Chantal Quinten, et al.
Translational Lung Cancer Research|March 11, 2026
Association of CT-assessed sarcopenia and the development of immune-related adverse events and overall survival: a multistate survival analysisErick Suazo-Zepeda, Marjolein A Heuvelmans, Douwe Postmus, et al.
Drug Safety|February 15, 2023
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey StudySonia Roldan Munoz, Douwe Postmus, Sieta T de Vries, et al.
Frontiers in Pharmacology|March 15, 2021
Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference StudySonia Roldan Munoz, Douwe Postmus, Sieta T de Vries, et al.
American Heart Journal|December 6, 2011
A trial-based economic evaluation of 2 nurse-led disease management programs in heart failureDouwe Postmus, Anees A Abdul Pari, Tiny Jaarsma, et al.
Dento Maxillo Facial Radiology|May 11, 2018
Diagnostic reliability of low dose multidetector CT and cone beam CT in maxillofacial trauma-an experimental blinded and randomized studyRomke Rozema, Michiel Hj Doff, Peter Ma van Ooijen, et al.
Biometrical Journal. Biometrische Zeitschrift|July 22, 2014
Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectivesEwout W Steyerberg, Moniek M Vedder, Maarten J G Leening, et al.
Pageof 8